JP2021519791A5 - - Google Patents

Info

Publication number
JP2021519791A5
JP2021519791A5 JP2020553490A JP2020553490A JP2021519791A5 JP 2021519791 A5 JP2021519791 A5 JP 2021519791A5 JP 2020553490 A JP2020553490 A JP 2020553490A JP 2020553490 A JP2020553490 A JP 2020553490A JP 2021519791 A5 JP2021519791 A5 JP 2021519791A5
Authority
JP
Japan
Prior art keywords
aav
mutant
capsid polypeptide
aav capsid
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020553490A
Other languages
English (en)
Japanese (ja)
Other versions
JP7378417B2 (ja
JP2021519791A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/025026 external-priority patent/WO2019191701A1/en
Publication of JP2021519791A publication Critical patent/JP2021519791A/ja
Publication of JP2021519791A5 publication Critical patent/JP2021519791A5/ja
Application granted granted Critical
Publication of JP7378417B2 publication Critical patent/JP7378417B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020553490A 2018-03-30 2019-03-29 増強されたヒト膵臓トロピズムを有する新規な組換えアデノ随伴ウイルスキャプシド Active JP7378417B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862651010P 2018-03-30 2018-03-30
US62/651,010 2018-03-30
US201862745226P 2018-10-12 2018-10-12
US62/745,226 2018-10-12
PCT/US2019/025026 WO2019191701A1 (en) 2018-03-30 2019-03-29 Novel recombinant adeno-associated virus capsids with enhanced human pancreatic tropism

Publications (3)

Publication Number Publication Date
JP2021519791A JP2021519791A (ja) 2021-08-12
JP2021519791A5 true JP2021519791A5 (cg-RX-API-DMAC7.html) 2022-02-21
JP7378417B2 JP7378417B2 (ja) 2023-11-13

Family

ID=66440120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020553490A Active JP7378417B2 (ja) 2018-03-30 2019-03-29 増強されたヒト膵臓トロピズムを有する新規な組換えアデノ随伴ウイルスキャプシド

Country Status (5)

Country Link
US (2) US11608510B2 (cg-RX-API-DMAC7.html)
EP (1) EP3774853A1 (cg-RX-API-DMAC7.html)
JP (1) JP7378417B2 (cg-RX-API-DMAC7.html)
CN (1) CN112004820B (cg-RX-API-DMAC7.html)
WO (1) WO2019191701A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3774853A1 (en) * 2018-03-30 2021-02-17 The Board of Trustees of the Leland Stanford Junior University Novel recombinant adeno-associated virus capsids with enhanced human pancreatic tropism
US11149256B2 (en) 2018-09-26 2021-10-19 California Institute Of Technology Adeno-associated virus compositions for targeted gene therapy
WO2021154414A2 (en) 2020-01-29 2021-08-05 Catalyst Biosciences, Inc. Gene therapy for hemophilia b with a chimeric aav capsid vector encoding modified factor ix polypeptides
TW202142554A (zh) * 2020-02-25 2021-11-16 澳洲兒童醫學研究所 腺相關病毒蛋白殼多肽及載體
US20230235353A1 (en) * 2020-03-19 2023-07-27 Ultragenyx Pharmaceutical Inc. Compositions and methods for reducing reverse packaging of cap and rep sequences in recombinant aav
CA3216420A1 (en) * 2021-04-26 2022-11-03 Seungil Han Adeno-associated viral vector capsids with improved tissue tropism
TW202309066A (zh) * 2021-04-27 2023-03-01 賓州大學委員會 衍生自豬的腺相關病毒衣殼及其用途
CA3219847A1 (en) * 2021-06-02 2022-12-08 Sander Jan Hendrik Van Deventer Adeno-associated virus vectors modified to bind high-density lipoprotein
WO2022266452A1 (en) * 2021-06-18 2022-12-22 Dyno Therapeutics, Inc. Capsid variants and methods of using the same
CA3222839A1 (en) * 2021-06-18 2022-12-22 Sylvain LAPAN Capsid variants and methods of using the same
WO2023034990A1 (en) * 2021-09-03 2023-03-09 Biomarin Pharmaceutical Inc. Aav capsid compositions and methods for delivery
JP2024534894A (ja) * 2021-09-03 2024-09-26 ビオマリン プハルマセウトイカル インコーポレイテッド Aavカプシド組成物及び送達方法
EP4396201A1 (en) * 2021-09-03 2024-07-10 BioMarin Pharmaceutical Inc. Aav capsid compositions and methods for delivery
US20240384242A1 (en) * 2021-09-03 2024-11-21 Biomarin Pharmaceutical Inc. Aav capsid compositions and methods for delivery
WO2023034980A1 (en) * 2021-09-03 2023-03-09 Bomarin Pharmaceutical Inc. Aav capsid compositions and methods for delivery
KR20240095539A (ko) 2021-10-08 2024-06-25 디노 테라퓨틱스, 인코포레이티드 캡시드 변이체 및 이의 사용 방법
CN114107231B (zh) * 2021-12-13 2023-08-18 重庆大学 实现全脑突触后神经元胞体标记的重组腺相关病毒及其应用
JP2025500891A (ja) 2021-12-15 2025-01-15 フラクティル ヘルス,インコーポレイテッド 代謝障害のための遺伝子治療
CN116686050B (zh) * 2021-12-30 2026-01-23 京东方科技集团股份有限公司 预测大分子间相互作用的负样本集的生成方法、预测大分子间相互作用的方法、模型的训练方法
CN114561337B (zh) * 2022-03-09 2023-10-03 广州源井生物科技有限公司 一种提高HepG2细胞克隆形成率的单克隆增强培养基和方法
GB202304767D0 (en) * 2023-03-30 2023-05-17 Ucl Business Ltd Synthetic AAV Capsid
CN121013858A (zh) * 2023-04-27 2025-11-25 俄勒冈健康与科学大学 靶向肾脏的aav衣壳及其使用方法
WO2024233135A1 (en) * 2023-05-05 2024-11-14 The Regents Of The University Of California Long-read sequencing of diverse dna libraries through barcode-labeled short reads
JP2026526743A (ja) * 2023-07-17 2026-08-10 オレゴン ヘルス アンド サイエンス ユニバーシティー 腎臓への薬物送達のための腎盂注入
GB202407863D0 (en) 2024-06-03 2024-07-17 Purespring Therapeutics Ltd Methods

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
AU8200191A (en) 1990-07-09 1992-02-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The High efficiency packaging of mutant adeno-associated virus using amber suppressions
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
ATE237694T1 (de) 1991-08-20 2003-05-15 Us Gov Health & Human Serv Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
US6093570A (en) 1995-06-07 2000-07-25 The University Of North Carolina At Chapel Hill Helper virus-free AAV production
CA2264482A1 (en) 1996-09-06 1998-03-12 The Trustees Of The University Of Pennsylvania An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
AU4645697A (en) 1996-09-11 1998-04-02 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Aav4 vector and uses thereof
US6200560B1 (en) 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
US6221349B1 (en) 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
EP1135468B1 (en) 1998-11-10 2010-01-06 University Of North Carolina At Chapel Hill Virus vectors and methods of making and administering the same
EP1572893B1 (en) 2001-11-09 2009-01-07 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES Production of adeno-associated virus in insect cells
DK2359869T3 (en) 2001-12-17 2019-04-15 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
PL2657248T3 (pl) * 2003-06-19 2017-09-29 Genzyme Corporation Wiriony AAV o zmniejszonej immunoreaktywności i ich zastosowanie
US9233131B2 (en) 2003-06-30 2016-01-12 The Regents Of The University Of California Mutant adeno-associated virus virions and methods of use thereof
US9441244B2 (en) 2003-06-30 2016-09-13 The Regents Of The University Of California Mutant adeno-associated virus virions and methods of use thereof
US8106180B2 (en) 2003-08-07 2012-01-31 Whitehead Institute For Biomedical Research Methods and products for expression of micro RNAs
US20050142581A1 (en) 2003-09-04 2005-06-30 Griffey Richard H. Microrna as ligands and target molecules
WO2005056761A2 (en) 2003-12-05 2005-06-23 Massachusetts Institute Of Technology REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi
KR100614827B1 (ko) 2004-05-06 2006-08-25 재단법인서울대학교산학협력재단 양방향 은닉 마코프 모델을 이용한 완숙한마이크로알엔에이 위치예측방법 및 이를 구현하기 위한컴퓨터 프로그램을 기록한 저장매체
ES2385679T3 (es) 2006-08-24 2012-07-30 Virovek, Inc. Expresión de células de insecto de genes con marcos de lectura abiertos superpuestos, métodos y composiciones de éstos
US8663624B2 (en) 2010-10-06 2014-03-04 The Regents Of The University Of California Adeno-associated virus virions with variant capsid and methods of use thereof
EP3795581A3 (en) * 2011-08-24 2021-06-09 The Board of Trustees of the Leland Stanford Junior University New avv capsid proteins for nucleic acid transfer
EP3470523A1 (en) * 2012-05-09 2019-04-17 Oregon Health & Science University Adeno associated virus plasmids and vectors
US11136557B2 (en) * 2013-05-31 2021-10-05 The Regents Of The University Of California Adeno-associated virus variants and methods of use thereof
NZ716102A (en) 2013-07-22 2021-12-24 The Children’S Hospital Of Philadelphia Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
WO2016054557A1 (en) * 2014-10-03 2016-04-07 University Of Massachusetts Novel high efficiency library-identified aav vectors
WO2016065001A1 (en) * 2014-10-21 2016-04-28 University Of Massachusetts Recombinant aav variants and uses thereof
GB201508026D0 (en) * 2015-05-11 2015-06-24 Ucl Business Plc Capsid
AU2016366549B2 (en) * 2015-12-11 2022-11-10 California Institute Of Technology Targeting peptides for directing adeno-associated viruses (AAVs)
CA3014637A1 (en) * 2016-02-16 2017-08-24 Mark A. Kay Novel recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
EP3774853A1 (en) * 2018-03-30 2021-02-17 The Board of Trustees of the Leland Stanford Junior University Novel recombinant adeno-associated virus capsids with enhanced human pancreatic tropism

Similar Documents

Publication Publication Date Title
JP7860169B2 (ja) 新規アデノ随伴ウイルス(aav)ベクター、低減されたカプシド脱アミド化を有するaavベクター、およびその使用
EP4114941A2 (en) Improved methods and compositions for modulating a genome
EP3609535B1 (en) Hbv vaccine
KR20240113624A (ko) Aav 캡시드 변이체 및 이의 용도
JP2021536244A5 (cg-RX-API-DMAC7.html)
BR112020017348A2 (pt) Vetores de vírus adenoassociados (aav), vetores de aav tendo desamidação de capsídeos reduzida e usos dos mesmos
IL311225A (en) Methods and compositions for genome modulation
JP2020511115A5 (cg-RX-API-DMAC7.html)
JP2022512912A5 (cg-RX-API-DMAC7.html)
Grisorio et al. Gene therapy for cardiac diseases: methods, challenges, and future directions
JP2019517790A5 (cg-RX-API-DMAC7.html)
JP2013518599A5 (cg-RX-API-DMAC7.html)
JP2021532776A5 (cg-RX-API-DMAC7.html)
JP2023138660A5 (cg-RX-API-DMAC7.html)
CN121488045A (zh) Aav衣壳变体及其用途
CN106459997A (zh) 用于疫苗应用的高效价病毒样囊泡的进化
JP2021514207A5 (cg-RX-API-DMAC7.html)
Kao et al. Improvement of gene delivery by minimal bacteriophage particles
JP2026515815A (ja) Cdkl5欠損に関連する障害の治療のための組成物及び方法
JP2019537446A5 (cg-RX-API-DMAC7.html)
JP2026063215A5 (cg-RX-API-DMAC7.html)
JP2021502102A5 (cg-RX-API-DMAC7.html)
JP2023551678A (ja) 免疫直交性aavおよび免疫ステルスcrispr-casの操作
JP2023515806A5 (cg-RX-API-DMAC7.html)
CN119923271A (zh) 包含结核病抗原的疫苗构建体